Bulk Pharmaceutical API Sources for LEVORPHANOL TARTRATE

Bulk Pharmaceutical API Sources for LEVORPHANOL TARTRATE

Vendor	Vendor Homepage	Vendor Sku	API Url
Glentham Life Sciences Ltd.		GL0385
VWR, Part of Avantor		75835-240
THE BioTek		bt-272673

Bulk Active Pharmaceutical Ingredient (API) Sources for: LEVORPHANOL TARTRATE

Last updated: July 30, 2025

---

Introduction

Levorphanol tartrate, a potent opioid analgesic, is primarily utilized for managing severe pain and has historically been prescribed in various clinical settings. Its formulation relies on high-quality active pharmaceutical ingredients (APIs), which must adhere to stringent regulatory standards to ensure safety and efficacy. As the demand for levorphanol tartrate continues within certain niche markets, pharmaceutical companies and compounding pharmacies seek reliable API sources that meet global quality and regulatory benchmarks. Understanding the landscape of bulk API suppliers for levorphanol tartrate is vital for stakeholders aiming to maintain compliance, optimize supply chains, and manage costs.

---

Regulatory Landscape and Industry Standards

The procurement of APIs for opioids like levorphanol tartrate involves rigorous regulatory oversight, given the compound's controlled status under increasingly strict drug enforcement policies worldwide. The U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regulatory agencies require APIs to originate from Good Manufacturing Practice (GMP)-compliant facilities. Manufacturers must provide comprehensive documentation covering purity standards, batch consistency, stability, and proof of regulatory approvals where applicable.

Global API suppliers must demonstrate compliance with standards such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and other pharmacopoeial monographs. Furthermore, international trade regulations influence sourcing decisions, especially regarding controls on opioid APIs.

---

Major Global API Suppliers for Levorphanol Tartrate

1. Contract Manufacturing Organizations (CMOs) and Major API Producers

While levorphanol tartrate is less widely manufactured compared to other opioids like morphine or fentanyl, select specialized API producers in countries with advanced chemical synthesis capacities supply bulk APIs to licensed manufacturers.

• North American Suppliers:
  Few North American API suppliers produce levorphanol tartrate due to regulatory constraints and market size. When available, they tend to provide GMP-grade APIs, primarily for niche pharmaceutical companies or government agencies.

• Indian Suppliers:
  India remains a leading global source of bulk APIs, including some opioid compounds, thanks to its large pharmaceutical manufacturing industry and cost-effective production. Companies such as Sun Pharmaceutical Industries and Divi's Laboratories are engaged in producing high-quality APIs, though levorphanol tartrate production remains limited and often outsourced to specialized contract manufacturers.

• Chinese Suppliers:
  China’s burgeoning API industry provides a competitive landscape for opioid APIs. Certain Chinese chemical firms with validated GMP facilities supply levorphanol tartrate, primarily to international markets under strict regulatory frameworks.

• European Suppliers:
  European pharmaceutical companies, such as Mylan and Sanofi, may produce APIs for specialized opioids, but levorphanol tartrate APIs are less common, often available only through specific licensing arrangements with licensed manufacturers.

2. Specialized API Suppliers and Distributors

• Bachem AG:
  Known for synthesizing complex APIs and intermediates, Bachem supplies high-grade APIs for research and clinical use. While they do not routinely offer levorphanol tartrate, partnerships can sometimes be established for custom synthesis.

• Chiral Corporation:
  Focuses on synthesizing chiral APIs, including opioids, with high enantiomeric purity. They may service custom requests for levorphanol tartrate or similar compounds, provided them with GMP-grade material.

• Alpha Chemical:
  Specializes in research-grade APIs, including opioids, with some offerings in controlled substances. Regulatory compliance and export controls are critical considerations in sourcing.

---

Key Considerations for API Procurement

• Regulatory Compliance:
  Ensure suppliers adhere to GMP standards and possess necessary certifications, such as Drug Master Files (DMFs) with the FDA. Verification of compliance minimizes regulatory liability and ensures consistent quality.

• Purity and Stability:
  APIs must meet USP or EP specifications, generally requiring purity above 99%. Certificates of Analysis (CoA) should be scrutinized for residual solvents, heavy metals, and enantiomeric purity.

• Supply Chain Reliability:
  Given the controlled status of levorphanol tartrate, establishing relationships with verified suppliers with reliable production capacities minimizes risks of shortages or delays.

• Pricing and Lead Times:
  Competitive pricing is vital, particularly in markets with constrained supply. Lead times from large-scale manufacturers tend to be longer; thus, early planning is advised.

• Legal and Trade Restrictions:
  Due to the opioid nature of levorphanol tartrate, all transactions must comply with international drug control treaties, including UN Single Convention on Narcotic Drugs and national legislation.

---

Emerging Trends and Challenges

• Increased Regulation:
  Stricter licensing, import-export controls, and increased scrutiny of controlled substance APIs have restricted supplier pools and increased lead times.

• Quality Assurance:
  A move toward supplier audits, third-party testing, and supply chain transparency aims to prevent counterfeit or substandard APIs entering the market.

• Manufacturing Innovations:
  Advances in asymmetric synthesis and greener manufacturing processes are improving the feasibility of producing high-quality levorphanol tartrate at scale and reducing costs.

• Market Concentration Risks:
  Heavy reliance on limited suppliers heightens risks; thus, diversification of sources and establishing strategic partnerships are recommended.

---

Conclusion

Securing bulk API sources for levorphanol tartrate involves navigating a complex landscape shaped by regulatory, quality, and geopolitical factors. While few suppliers dominate the market, adherence to GMP standards remains non-negotiable to meet global regulatory requirements. Indian and Chinese manufacturers represent primary sources, often accessible through regulatory-approved distributors or CMOs. Pharmaceutical entities must prioritize regulatory diligence, supply chain transparency, and quality assurance to mitigate risks associated with opioid APIs.

---

Key Takeaways

• Regulatory compliance is central: GMP certification and proper documentation are mandatory for sourcing levorphanol tartrate API.
• Few suppliers dominate the market: Indian and Chinese manufacturers are primary, but supplier verification is critical.
• Quality assurance mitigates risks: Certificates of Analysis and third-party testing confirm API purity and stability.
• Supply chain resilience is essential: Diversify sources to avoid shortages due to regulatory or geopolitical disruptions.
• Stay compliant with regulations: Strict adherence to international drug control treaties and local legislation is non-negotiable for lawful procurement.

---

FAQs

1. Are there FDA-approved manufacturers of levorphanol tartrate API?
Currently, few, if any, FDA-approved manufacturers produce levorphanol tartrate API specifically for commercial distribution. Most supplies originate from GMP-compliant facilities in India and China, catering primarily to licensed manufacturers under strict regulatory oversight.

2. Is bulk purchase of levorphanol tartrate API cost-effective?
Bulk procurement can reduce costs significantly; however, costs vary based on purity, supplier reputation, and regulatory compliance. High standards and controlled substance regulations often elevate prices.

3. What are the legal considerations for procuring levorphanol tartrate API internationally?
All transactions must comply with international and national drug control laws, including licensing, record-keeping, and reporting requirements. Engaging with verified suppliers with proper licenses is essential.

4. Can research institutions source levorphanol tartrate API for experimental use?
Yes, research-grade APIs are available for authorized institutions, but issuance depends on local regulations, and proper licensing is necessary due to the controlled nature of the compound.

5. How can companies verify the quality of a levorphanol tartrate API supplier?
Verification involves reviewing GMP certifications, requesting Certificates of Analysis, auditing manufacturing facilities, and ensuring supplier compliance with pharmacopoeial standards and regulatory agencies.

---

References

[1] U.S. Food and Drug Administration. Guidance for Industry: Good Manufacturing Practice Regulations for Drugs.
[2] European Pharmacopoeia. Monograph on Levorphanol Tartrate.
[3] World Health Organization. Model List of Essential Medicines, 21st edition.
[4] International Narcotics Control Board. Report on the Global Pharmaceutical Market, 2022.
[5] Chemical & Pharmaceutical Industry Reports. Global API Market Analysis, 2022.